Hint mode is switched on Switch off

Tarsus Pharmaceuticals, ordinary share
US87650L1035, TARS

Add a stock to WL
Choose all Reset all
Tarsus Pharmaceuticals, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutic candidates to address large market opportunities, initially in ophthalmic conditions where there are limited treatment alternatives.
  • Issuer
  • Full borrower / issuer name
    Tarsus Pharmaceuticals Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TARS
  • Placement
    16.10.2020
  • Lock up period
    180
  • Number of papers
    5,500,000
  • Volume of raised funds
    88 mln USD
  • Placement share
    28.56%
  • Final placement price
    16 USD
  • Price change since placement date
    131.25%
  • By capitalization
    308.14 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TARS
  • Placement
    04.05.2022
  • Lock up period
    180
  • Number of papers
    5,600,000
  • Volume of raised funds
    75.6 mln USD
  • Placement share
    21.29%
  • Final placement price
    13.5 USD
  • Price change since placement date
    174.07%
  • By capitalization
    355.03 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    TARS
  • Placement
    01.03.2024
  • Lock up period
    180
  • Number of papers
    37,023,690
  • Volume of raised funds
    90 mln USD
  • Placement share
    7.6%
  • Final placement price
    32 USD
  • Price change since placement date
    15.63%
  • By capitalization
    1,184.76 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2024
I q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Related Stock indices

Indicators

News

08/05/2024 Tarsus Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
19/04/2024 Tarsus Pharmaceuticals: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Regulation Fd Disclosure, Financial Statements And Exhibits
05/03/2024 Tarsus Pharmaceuticals: Other Events
27/02/2024 Tarsus Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits
11/01/2024 Tarsus Pharmaceuticals: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
All organization news

Holders

Industry Leaders

Registration is required to get access.